The effects of exogenous CCK-8 on the acquisition and expression of morphine-induced CPP

Neuroscience Letters

Volumn 510, Issue 1, 2012, Pages 24-28

  Wen, Di ^a   Cong, Bin ^a   Ma, Chunling ^a   Yang, Shengchang ^a   Yu, Hailei ^a   Ni, Zhiyu ^a   Li, Shujin ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Acquisition; Cholecystokinin octapeptide; Conditioned place preference; Expression; Morphine; Reward

Indexed keywords

CHOLECYSTOKININ OCTAPEPTIDE; MORPHINE;

ARTICLE; AVERSION; DRUG DEPENDENCE; INFORMATION PROCESSING; LOCOMOTION; OPIATE ADDICTION; PLACE PREFERENCE; PRIORITY JOURNAL; REWARD;

ANALGESICS, OPIOID; ANIMALS; AVOIDANCE LEARNING; CONDITIONING (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; MALE; MORPHINE; MOTOR ACTIVITY; OPIOID-RELATED DISORDERS; RATS; RATS, WISTAR; REWARD; SINCALIDE; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84862827714     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.12.063     Document Type: Article

References (31)

1. Alttoa A., Harro J. Effect of CCK1 and CCK2 receptor blockade on amphetamine-stimulated exploratory behavior and sensitization to amphetamine. Eur. Neuropsychopharmacol. 2004, 14:324-331.
2. Becker C., Pohl M., Thiebot M.H., Collin E., Hamon M., Cesselin F., Benoliel J.J. Delta-opioid receptor-mediated increase in cortical extracellular levels of cholecystokinin-like material by subchronic morphine in rats. Neuropharmacology 2000, 39:161-171.
3. Benoliel J.J., Mauborgne A., Bourgoin S., Legrand J.C., Hamon M., Cesselin F. Opioid control of the in vitro release of cholecystokinin-like material from the rat substantia nigra. J. Neurochem. 1992, 58:916-922.
4. Crawley J.N., Corwin R.L. Biological actions of cholecystokinin. Peptides 1994, 15:731-755.
5. Dauge V., Sebret A., Beslot F., Matsui T., Roques B.P. Behavioral profile of CCK2 receptor-deficient mice. Neuropsychopharmacology 2001, 25:690-698.
6. DeSantana J.M., da Silva L.F., Sluka K.A. Cholecystokinin receptors mediate tolerance to the analgesic effect of TENS in arthritic rats. Pain 2010, 148:84-93.
7. Dourish C.T., O'Neill M.F., Coughlan J., Kitchener S.J., Hawley D., Iversen S.D. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat. Eur. J. Pharmacol. 1990, 176:35-44.
8. Faris P.L., Komisaruk B.R., Watkins L.R., Mayer D.J. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science 1983, 219:310-312.
9. Hadjiivanova C., Belcheva S., Belcheva I. Cholecystokinin and learning and memory processes. Acta Physiol. Pharmacol. Bulg. 2003, 27:83-88.
10. Hebb A.L., Poulin J.F., Roach S.P., Zacharko R.M., Drolet G. Cholecystokinin and endogenous opioid peptides: interactive influence on pain, cognition, and emotion. Prog. Neuropsychopharmacol. Biol. Psychiatry 2005, 29:1225-1238.
11. Heinricher M.M., Neubert M.J. Neural basis for the hyperalgesic action of cholecystokinin in the rostral ventromedial medulla. J. Neurophysiol. 2004, 92:1982-1989.
12. Higgins G.A., Nguyen P., Sellers E.M. Morphine place conditioning is differentially affected by CCKA and CCKB receptor antagonists. Brain Res. 1992, 572:208-215.
13. Hirosue Y., Inui A., Miura M., Nakajima M., Okita M., Himori N., Baba S., Kasuga M. Effects of CCK antagonists on CCK-induced suppression of locomotor activity in mice. Peptides 1992, 13:155-157.
14. Itoh S., Katsuura G., Maeda Y. Caerulein and cholecystokinin suppress beta-endorphin-induced analgesia in the rat. Eur. J. Pharmacol. 1982, 80:421-425.
15. Lu L., Huang M., Liu Z., Ma L. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats. Neuroreport 2000, 11:829-832.
16. Lu L., Huang M., Ma L., Li J. Different role of cholecystokinin (CCK)-A and CCK-B receptors in relapse to morphine dependence in rats. Behav. Brain Res. 2001, 120:105-110.
17. Lu L., Zhang B., Liu Z.Y., Zhang Z.Y. Reactivation of cocaine conditioned place preference induced by stress is reversed by cholecystokinin-B receptors antagonist in rats. Brain Res. 2002, 954:132-140.
18. Mannisto P.T., Lang A., Harro J., Peuranen E., Bradwejn J., Vasar E. Opposite effects mediated by CCKA and CCKB receptors in behavioural and hormonal studies in rats. Naunyn. Schmiedebergs Arch. Pharmacol. 1994, 349:478-484.
19. Mitchell J.M., Bergren L.J., Chen K.S., Fields H.L. Cholecystokinin is necessary for the expression of morphine conditioned place preference. Pharmacol. Biochem. Behav. 2006, 85:787-795.
20. Noble F., Wank S.A., Crawley J.N., Bradwejn J., Seroogy K.B., Hamon M., Roques B.P. International Union of Pharmacology. XXI. Structure, distribution, and functions of cholecystokinin receptors. Pharmacol. Rev. 1999, 51:745-781.
21. Panerai A.E., Rovati L.C., Cocco E., Sacerdote P., Mantegazza P. Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin. Brain Res. 1987, 410:52-60.
22. Reum T., Fink H., Marsden C.A., Morgenstern R. Extracellular dopamine in the anterior nucleus accumbens is distinctly affected by ventral tegmental area administration of cholecystokinin and apomorphine: data from in vivo voltammetry. Neuropeptides 1998, 32:161-166.
23. Rezayat M., Nikfar S., Zarrindast M.R. CCK receptor activation may prevent tolerance to morphine in mice. Eur. J. Pharmacol. 1994, 254:21-26.
24. Rezayof A., Nazari-Serenjeh F., Zarrindast M.R., Sepehri H., Delphi L. Morphine-induced place preference: involvement of cholinergic receptors of the ventral tegmental area. Eur. J. Pharmacol. 2007, 562:92-102.
25. Rompre P.P., Boye S.M. Opposite effects of mesencephalic microinjections of cholecystokinin octapeptide and neurotensin-(1-13) on brain stimulation reward. Eur. J. Pharmacol. 1993, 232:299-303.
26. Sebret A., Lena I., Crete D., Matsui T., Roques B.P., Dauge V. Rat hippocampal neurons are critically involved in physiological improvement of memory processes induced by cholecystokinin-B receptor stimulation. J. Neurosci. 1999, 19:7230-7237.
27. Su R.B., Lu X.Q., Huang Y., Liu Y., Gong Z.H., Wei X.L., Wu N., Li J. Effects of intragastric agmatine on morphine-induced physiological dependence in beagle dogs and rhesus monkeys. Eur. J. Pharmacol. 2008, 587:155-162.
28. Tzschentke T.M. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict. Biol. 2007, 12:227-462.
29. Wang X.J., Fan S.G., Ren M.F., Han J.S. Cholecystokinin-8 suppressed 3H-etorphine binding to rat brain opiate receptors. Life Sci. 1989, 45:117-123.
30. Wen D., Ma C.L., Cong B., Yu H.L., Yu F., Ni Z.Y., Li S.J. Interaction of CCK-8 and endogenous opioid system in the opioid dependence. Chin. Pharmacol. Bull. 2010, 26:421-426.
31. Wen D., Ma C.L., Cong B., Zhang Y.J., Yang S.C., Meng Y.X., Yu F., Ni Z.Y., Li S.J. Effects of CCK-8 and its receptor antagonists given intracerebroventricularly on withdrawal symptom of morphine dependent rats. Chin. Pharmacol. Bull. 2011, 27:1368-1373.